Project ALS

To the Project ALS Family: We are proud to announce that prosetin, a novel ALS drug candidate developed at the Project ALS Therapeutics Core at Columbia, has been acquired for commercial development by a new company, ProJenX. Read the press release here: prn.to/3JtRymM

Still not over marathon weekend! 🏅

We couldn't have asked for a better team to represent Project ALS this year. To every runner who spent months training and fundraising, thank you. 💐

Until next year, #NYCMarathon!

For some of us, #ALS is something we've known about for years. For others, it was a diagnosis that changed everything.

However ALS entered your life, your story matters, and we'd love to hear it. How did ALS become part of your story? Share with us in the comments below. ⬇

Before the #NYCMarathon we got together with some of our Team Project ALS runners for a little pre-marathon lunch. 🍝

To all of our Team Project ALS runners, thank you for putting in the miles and raising funds to support ALS research. 🏅

For nearly three decades, we have brought all of these people together around one goal: to move the best ALS research forward, faster, toward effective treatments and a cure.

Research may happen in the lab, but it is made possible by all of us.

That’s the Project ALS family.